N-acetylcysteine for COPD: the evidence remains inconclusive--authors' reply.
State Key Laboratory of Respiratory Disease, National Clinical Trial Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Jin-Ping
JP
Zheng
State Key Laboratory of Respiratory Disease, National Clinical Trial Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China. Electronic address: nanshan@vip.163.com.
Nan-Shan
NS
Zhong
D000111:Acetylcysteine / Q000008:administration & dosage*; D005260:Female; D016166:Free Radical Scavengers / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000188:drug therapy*
D016166:Free Radical Scavengers; D000111:Acetylcysteine